1. Home
  2. PULM vs AIRI Comparison

PULM vs AIRI Comparison

Compare PULM & AIRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PULM
  • AIRI
  • Stock Information
  • Founded
  • PULM 2003
  • AIRI 1979
  • Country
  • PULM United States
  • AIRI United States
  • Employees
  • PULM N/A
  • AIRI N/A
  • Industry
  • PULM Biotechnology: Pharmaceutical Preparations
  • AIRI Military/Government/Technical
  • Sector
  • PULM Health Care
  • AIRI Industrials
  • Exchange
  • PULM Nasdaq
  • AIRI Nasdaq
  • Market Cap
  • PULM 18.3M
  • AIRI 15.4M
  • IPO Year
  • PULM N/A
  • AIRI N/A
  • Fundamental
  • Price
  • PULM $4.87
  • AIRI $3.24
  • Analyst Decision
  • PULM
  • AIRI
  • Analyst Count
  • PULM 0
  • AIRI 0
  • Target Price
  • PULM N/A
  • AIRI N/A
  • AVG Volume (30 Days)
  • PULM 17.6K
  • AIRI 46.9K
  • Earning Date
  • PULM 10-16-2025
  • AIRI 11-13-2025
  • Dividend Yield
  • PULM N/A
  • AIRI N/A
  • EPS Growth
  • PULM N/A
  • AIRI N/A
  • EPS
  • PULM N/A
  • AIRI N/A
  • Revenue
  • PULM $3,000.00
  • AIRI $52,277,000.00
  • Revenue This Year
  • PULM N/A
  • AIRI N/A
  • Revenue Next Year
  • PULM $134.88
  • AIRI $3.53
  • P/E Ratio
  • PULM N/A
  • AIRI N/A
  • Revenue Growth
  • PULM N/A
  • AIRI N/A
  • 52 Week Low
  • PULM $2.00
  • AIRI $2.80
  • 52 Week High
  • PULM $10.40
  • AIRI $6.28
  • Technical
  • Relative Strength Index (RSI)
  • PULM 50.82
  • AIRI 51.32
  • Support Level
  • PULM $4.55
  • AIRI $3.23
  • Resistance Level
  • PULM $4.95
  • AIRI $3.36
  • Average True Range (ATR)
  • PULM 0.21
  • AIRI 0.11
  • MACD
  • PULM 0.02
  • AIRI 0.00
  • Stochastic Oscillator
  • PULM 46.72
  • AIRI 54.41

About PULM Pulmatrix Inc.

Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).

About AIRI Air Industries Group

Air Industries Group is an aerospace and defense company. Its manufactures and designs structural parts and assemblies that focus on flight safety, including landing gear, arresting gear, engine mounts, flight controls, throttle quadrants, jet engines, and other components. The company also provides sheet metal fabrication of aerostructures, tube bending, and welding services.

Share on Social Networks: